Dee Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-07-2024
- Paid Up Capital ₹ 0.39 M
as on 09-07-2024
- Company Age 27 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.80 M
as on 09-07-2024
- Revenue -40.33%
(FY 2020)
- Profit -35.78%
(FY 2020)
- Ebitda 532.49%
(FY 2020)
- Net Worth 0.19%
(FY 2020)
- Total Assets -2.89%
(FY 2020)
About Dee Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.39 M.
The company currently has active open charges totaling ₹0.80 M.
Madhu Gupta and Rajesh Gupta serve as directors at the Company.
- CIN/LLPIN
U24232RJ1997PTC014144
- Company No.
014144
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationJaipur, Rajasthan
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dee Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhu Gupta  | Director | 21-Aug-1997 | Current |
| Rajesh Gupta | Director | 21-Aug-1997 | Current |
Financial Performance and Corporate Structure Insights of Dee Drugs.
Dee Drugs Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 40.33% decrease. The company also saw a substantial fall in profitability, with a 35.78% decrease in profit. The company's net worth moved up by a moderate rise of 0.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dee Drugs?
In 2020, Dee Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
17 years 9 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Bank Of Rajasthan Limited Creation Date: 18 May 1999 | ₹0.40 M | Open |
The Bank Of Rajasthan Limited Creation Date: 01 May 1999 | ₹0.40 M | Open |
How Many Employees Work at Dee Drugs?
Unlock and access historical data on people associated with Dee Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dee Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dee Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
